bpc-157 fda status wada ban 2026 Is Legal in 2026? Compounding Explained WADA's 2022 Prohibited List now
Description
Ingredient disclosure
Product is sold strictly for laboratory scientific research (RUO), not for human consumption
Compliance THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY
If the panel recommends inclusion which most observers expect given Kennedy's public support you could see pharmacy-compounded BPC-157, TB-500, and the others available by late 2026 or early 2027
HOXA5 counteracts the function of pathological scar-derived fibroblasts by partially activating p53 signaling
